
Depew Fine Chemical Co., Ltd., founded in 2004, is located in Hangzhou,the capital of Zhejiang Province-China's major manufacturing base for pharmaceutical raw materials. We established Depew Chemical Japan Co., Ltd. in 2016 and subsequently launched Tokuka Pharma LLC in the United States in 2025, forming a sound overseas business layout.
Depew specializes in the R&D, marketing, and manufacturing of Active Pharmaceutical Ingredients, intermediates, electronic, cosmetic, polymer and biological materials. In addition, we offer patent licensing and CDMO services.
Maintaining stable partnerships with numerous domestic manufacturers and professional research institutions, we possess comprehensive industry information resources and act as a reliable business bridge linking global markets.

Depew Chemical Japan Co., Ltd., established in 2016, is a professional trading company dedicated to providing high-quality APIs, pharmaceutical intermediates, and other chemical products to clients both domestically and internationally. Depew Japan also offers CRO and CDMO services. Equipped with professional QA and regulatory affairs team, Depew Japan provides services including GMP audit guidance for manufacturers, Foreign Manufacturer Accreditation application support, Japanese DMF registration, and comprehensive compliance solutions for various pharmaceutical regulatory requirements.

Tokuka Pharma LLC established in 2025, is a pharmaceutical and chemical trading company registered in Maryland, USA. The company provides CDMO services as well as regulatory and market access consulting for international pharmaceutical registration. Tokuka engages in global trading activities of pharmaceuticals, chemicals, and advanced materials, while also assisting US pharmaceutical companies in obtaining drug approvals and market access permits for international markets.

Our corporate strategy is to continuously provide better products and services to our clients.
We look forward to cooperating sincerely with partners on the basis of mutual benefit and development.

